Cosmos Health Expands Share Buyback to 4.14 Million Shares; Continues Open Market Repurchases

Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, today announced that it has repurchased an additional 80,000 shares of its common stock in the open market at an average price of approximately $0.2503 per share.

The Company has now repurchased a total of 4,140,000 shares for approximately $831,000 under its previously announced share repurchase program of up to $5 million.

Under the program, Cosmos Health may repurchase shares from time to time in the open market, through privately negotiated transactions, or through other permitted means, in accordance with SEC Rules 10b5-1 and 10b-18 and other applicable restrictions.

The Company intends to continue making open market repurchases, subject to market conditions, under the program, which expires on December 31, 2026, and may be renewed at the Company’s sole discretion.

Greg Siokas, CEO of Cosmos Health, stated: "We continue to repurchase our shares because we believe they trade well below the intrinsic value of our business, reflecting our commitment to long-term shareholder value.”

About Cosmos Health Inc. Cosmos Health Inc. (Nasdaq:COSM), incorporated in 2009 in Nevada, is a diversified, vertically integrated global healthcare group. The Company owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life®, Mediterranation®, bio-bebe®, C-Sept® and C-Scrub®.

Through its subsidiary Cana Laboratories S.A., licensed under European Good Manufacturing Practices (GMP) and certified by the European Medicines Agency (EMA), it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devic...